Victorian Parliamentary Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017

Similar documents
September Contact John Rogerson Chief Executive Officer Alcohol and Drug Foundation Executive Summary adf.org.

Needle and Syringe Programs - 17 October 2013

Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014

ESTABLISHMENT OF SUPERVISED INJECTING FACILITY IN VICTORIA SUBMITTED BY THE SALVATION ARMY

Hepatitis C Strategy. About us. What is hepatitis C?

15 Years of Supervised Drug Consumption Vancouver, Canada

Victorian AIDS Council Gay Men s Health Centre

Taking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre

Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201

>Hepatitis NSW will continue to

FDAP Drug & Alcohol Professional Certification Workplace Assessment

Evidence-based interventions for managing illicit drug dependence

22 April 2002 Central Australian Aboriginal Congress Submission: Taskforce on Illicit Drugs

Addiction and Substance misuse pathways

Leading Australia towards the elimination of viral hepatitis

STAFF REPORT ACTION REQUIRED. Supervised Injection Services in Toronto SUMMARY. Date: June 21, Board of Health. To: Medical Officer of Health

PERFORMANCE AND IMAGE ENHANCING DRUGS

Substance use and misuse

Dumfries and Galloway Alcohol and Drug Partnership. Strategy

Updated Activity Work Plan : Drug and Alcohol Treatment NEPEAN BLUE MOUNTAINS PHN

Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian

The science of the mind: investigating mental health Treating addiction

1 HB By Representative Williams (JD) 4 RFD: Health. 5 First Read: 09-JAN-18 6 PFD: 11/28/2017. Page 0

ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE. Dr. David Williams Chief Medical Officer of Health

WA DRUG ABUSE STRATEGY OFFICE

Drug Use, Harm Reduction, and HIP

Borders Alcohol & Drugs Partnership Workforce Development and Training Directory

Pharmacotherapy. Position Paper: Pharmacotherapy. Introduction. Victorian Alcohol and Drug Association (VAADA) Issued August 2011

Questions & Answers. What are the risks associated with consumption drug use?

Harm Reduction and Medical Respite (Dead People Don t Recover) Alice Moughamian, RN,CNS Dave Munson MD

Drug Consumption Rooms Worldwide

A Community Legal Centre. The Secretary Legal and Social Issues Committee Parliament House, Spring Street EAST MELBOURNE VIC 3002

Should buprenorphine be covered for maintenance treatment in opioid dependent persons?

Not just naloxone: Insights into emerging models to reduce drug harms

who use drugs in order to assist them in reducing harm while in the cycle of addiction

Vision and eye healthcare study in residential aged care facilities

Building a New Approach to Health Care Services for Hard to Reach Clients

COMMUNITY ENGAGEMENT SUMMARY REPORT

H5VL 04 (SFH AB2) Support Individuals Who are Substance Users

REPORT ON EXPLORATORY SITE VISITS FOR COMPREHENSIVE USER ENGAGEMENT SITE (CUES)

IMPORTANCE OF PEER-BASED SERVICES & NEEDLE & SYRINGE PROGRAMS (NSP)

Re Joint Committee on Law Enforcement Inquiry into crystal methamphetamine (ice)

New South Wales Needle and Syringe Program Enhanced Data Collection

Ministry of Health and Long-Term Care Overdose Prevention Sites: User Guide for Applicants

Part of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia

A Framework for Optimal Cancer Care Pathways in Practice

HARM REDUCTION IN CANADA LESSONS LEARNED AND REFLECTIONS. Marilou Gagnon, RN, PhD Associate Professor School of Nursing University of Victoria

OPIOIDS IN AMERICA. A complex crisis. A comprehensive response.

14. EMPLOYMENT Occupational segregation Commonwealth Employment by industry for males and females who identify as

HCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report

Historical Perspectives

The Cancer Council NSW. Submission to the Legislative Assembly Public Accounts Committee. Inquiry into NSW State Plan Reporting

PH52. Audit tool for the implementation of. NICE public health guidance 52 Needle and syringe programmes

Responding to B.C. s Illegal Drug Overdose Epidemic

DRUG DIVERSION STUDY TOUR ANNIE MADDEN EXECUTIVE OFFICER AUSTRALIAN INJECTING AND ILLICIT DRUG USERS LEAGUE (AIVL)

Background: Kirketon Road Centre

Senate Finance and Public Administration References Committee Inquiry into Domestic Violence and Gender Inequality

HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons

Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario

Public Health Association of Australia: Policy-at-a-glance Pharmaceutical Drug Misuse Policy

CABINET PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND

Helping Australians make smart health choices

19/08/2014. What is Injection Safety?

Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary

Victorian Aboriginal Legal Service Co-operative Ltd.

OUTCOMES OF TRAINING GENERAL PRACTITIONERS TO PRESCRIBE METHADONE

Addiction Therapy-2014

What s The Harm? Conference 2015: Where are we now.what s Next? Beth Whalen

Borders Alcohol & Drugs Partnership Workforce Development and Training Directory

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

Eliminating Viral Hepatitis in Australia: Where are we in 2017?

Position is based Access Health & Community: Hawthorn and Doncaster East Manager, Alcohol and Other Drug Service

Item No: 8. Meeting Date: Wednesday 12 th December Glasgow City Integration Joint Board

A handbook for people who have injected drugs

QuADS Organisational Standards and Professional Competencies in needle exchange

DANII Foundation. Pre-Budget Submission Extending Lifesaving CGM Technology and

Training Objectives. By the end of this session you will be able to: 2. Recognize key principles of harm reduction.

The impact of economic recession on drug users and drug treatment

Take Home Naloxone elearning Module Script

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.

Services and Support Information Leaflet

Opioid-related death is the leading cause of death for individuals

Carol Strike, PhD & Tara Marie Watson, PhD and the Working Group on Best Practice for Harm Reduction Programs in Canada

POLICY POSITION. Access to Hepatitis C Treatments

1. Respond to social and political agendas relating to young people and the youth services sector

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success

Preventing Harm from Substance Use: Harm Reduction. July 6, Dr. Murray Fyfe Medical Health Officer Vancouver Island Health Authority

TREATMENT OF RECENTLY ACQUIRED HEPATITIS C VIRUS INFECTION (ATAHC II)

BROMLEY JOINT STRATEGIC NEEDS ASSESSMENT Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes.

Primary Health Networks

Falls Prevention in Older People: Policy and Practice. Professor Stephen Lord Prince of Wales Medical Research Institute Sydney, Australia

Working for Health, Justice and Partnership

WELCOME TO THE CRACKS IN THE ICE WEBINAR SERIES

The Real Estate Institute of New South Wales Limited. Inquiry into Biotoxin-related Illnesses in Australia. 30 July 2018

City of Moonee Valley Draft MV 2040 Strategy

Inquiry into the Social Services Legislation Amendment (Welfare Reform) Bill Submission to Senate Community Affairs Legislation Committee

Submission to Parliamentary Joint Committee on Law Enforcement Inquiry into Crystal Methamphetamine (Ice)

Transcription:

Victorian Parliamentary Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017 19 April 2017 That the Government: VHA Recommendations Implement a time limited trial of an integrated supervised injecting facility (SIF) similar to that recommended by Coroner Jacqui Hawkins at a site where there is significant drug trade and consumption of heroin. The facility should offer a range of services in addition to supervised injecting including (but not limited to) medical care, pharmacotherapy, referral to drug rehabilitation, housing, legal and other support services. Give consideration to this trial being part of a research study examining the operational and clinical benefits of operating a SIF in a Victorian context. Plan for a wider implementation of SIFs in areas of need across metropolitan Melbourne and regional Victoria at the conclusion of this trial. Background Health and social problems related to heroin consumption The Victorian Healthcare Association (VHA) is pleased to present our submission to the Victorian Parliamentary Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017. The VHA and our members are concerned that appropriate strategies to minimise the harmful effects of heroin consumption which results in significant loss of life, injury, illness and use of substantial health resources are implemented to better support heroin users. VHA Submission - Page 1

Heroin consumption is a high risk activity and one of its most common side-effects is overdose. 1 In 2015, heroin overdose accounted for 172 deaths in Victoria and in the City of Yarra, where the problem is worse than in any other Victorian municipality, there was a fatal overdose more than once every three weeks. 2 The problems associated with heroin use are significant for health services. In 2010/11, over 1500 hospitalisations attributable to opioid consumption were reported in Victoria, and Ambulance Victoria attended over 1200 non-fatal heroin overdoses in metropolitan Melbourne. 3 It is in this enviroment that many community health services commit significant resources and employ a range of strategies including needle and syringe programs, outreach services, naloxone distribution and education to support this marginalised and difficult to reach group. 4 The VHA believes that the Victorian Government should carefully consider the implementation of a trial of a supervised injection facility to improve health outcomes and reduce deaths from heroin overdose, facilitate more efficient use of health care resources and improve public safety. Prevalence and types of supervised injecting facilities (SIFs) SIFs have existed in Europe for over 30 years and were initially created to combat the spread of blood borne diseases such as Human Immunodeficiency Virus (HIV) and Hepatitis C. 5 In 2016, there were 90 SIFs worldwide. 6 There are two main types of SIFs: 7 Specialised SIFs that are usually part of a larger facility and offer other services such as needle and syringe programs and medical care, and can act as referral points to drug rehabilitation. 8 1 State Government of Victoria. Better Health Channel. Heroin. https://www.betterhealth.vic.gov.au/health/healthyliving/heroin Accessed 6/4/17 2 Coroners Court of Victoria. Finding Inquest into the death of Ms.A. http://www.coronerscourt.vic.gov.au/home/coroners+written+findings/findings+-+241816+ms+a. Accessed 31/3/17 3 State Government of Victoria. The Victorian Drug Statistics Handbook. Report No 14. Patterns of Drug Use and related harm in Victoria for the period July 2010 to June 2011 4 Coroners Court of Victoria. op.cit. Pg. 9 5 Lingle, C.A (2011). A critical review of the effectiveness of safe injection facilities as a harm reduction strategy. Indiana University of Pennsylvania 6 Harm Reduction International (2016). Global State of Harm Reduction Overview. https://www.hri.global/contents/1739, page 18. 7 Lingle, C.A (2011). op.cit. Pg. 10 8 Lingle, C.A (2011). op.cit. Pg. 10 VHA Submission - Page 2

Integrated SIFs, which are usually part of a larger network of services for users and homeless people in addition to providing supervision for drug consumption. 9 Benefits of Safe Injection Facilities including the facility at Kings Cross Health Benefits The only facility in Australia is a specialised SIF which opened in 2001 in Kings Cross. The Kings Cross facility provides a clean and safe environment for consumption of injectable drugs under the supervision of a health professional who can also intervene quickly in the event of an overdose, access to clean injecting equipment and a place for disposal, 10 and education about safe injecting practices. The most compelling reason to trial a safe injecting facility in Melbourne is that it will save lives of heroin users that experience overdose. From 2001 2010, the Kings Cross SIF managed 3000 overdoses from which there were no reported deaths within the facility 11 and similar outcomes have been reported in other studied SIFs around the world. 12 The main reason for this was that overdoses could be managed quickly before symptoms progressed. Similarly, in the safe environment offered by the SIF, users had more time to consume the drug, reducing the possibility of overdose. 13 Education provided by staff at the Kings Cross SIF has led to safer injection practices, reduced sharing of needles and users being able to better recognise the signs of overdose in themselves and others. 14 Similarly, there were also fewer reported notifications of both Hepatitis C and HIV in the Kings Cross postcode and increased knowledge of their transmission by clients using the SIF. 15 9 Lingle, C.A (2011). op.cit. Pg. 10 10 NSW Health. Further evaluation of the Medically Supervised Injecting Centre during the extended Trial period (2007-2011). www.health.nsw.gov.au/mentalhealth/programs/da/documents/msic-kpmg.pdf Accessed 31/3/17 11 NSW Health. op cit Pg ix (Executive Summary) & Pg 10 12 Lingle, C.A (2011). op.cit. Pg. 25-26 13 Stoltz, J.A; Wood, E; Small, W; Li, K; Tyndall, M; Mintaner, J; & Kerr, T. (2007) Changes in injecting practices associated with the use of a medically supervised safer injection facility. Journal of Public health (Oxf). 29(1): 25-39. cited in Lingle, C.A (2011). op.cit. Pg. 23-24 14 NSW Health. op cit. Pg 11 15 NSW Health. op cit. Pg xi (Executive Summary) VHA Submission - Page 3

More efficient use of health system resources Our members report that the first responders to many overdoses are staff of community health services who often reach the patient before ambulance services. This response can require the presence of up to ten staff 16 who are diverted from their other (usually clinical) activities. There is an opportunity cost associated with this response scheduled clinical and non-clinical services are either interrupted or cannot be provided in this time, and the cost is borne by the organisation, general practitioners, other clinicians and the community. There are also significant costs associated with responses by emergency services such as ambulances and the fire brigade. Indeed, North Richmond Community Health Service responded to 56 overdoses in 2015 17 resulting in significant disruption to services. Overdoses require an emergency response. However, community based organisations are neither set up nor funded to operate like hospital emergency departments or ambulance services. These situations can be traumatic and dangerous for attending staff as there are often friends and family of the overdose patient present, some of whom may also be drug affected. The Victorian Government has increased its focus on the safety and security of Victoria s frontline clinical workforce for which it is to be commended and implementing measures to reduce the likelihood of their exposure to these difficult situations will be a further step in the right direction. The evaluation of the Kings Cross facility demonstrates significant cost benefits of allowing users to inject heroin in supervised facilities compared to relying solely on measures such as needle and syringe programs, training of community members in the administration of naloxone, education and direct emergency intervention (although these methods should all be retained if a SIF is introduced). 18 Experience at the Kings Cross facility showed that quick intervention saved lives in many overdose situations which also reduced the number of overdose-related ambulance call outs required during the opening hours of the SIF. 19 The Kings Cross facility has referred many heroin users into important health and social services such as drug rehabilitation, housing and legal supports. 20 This is often a slow process. Heroin users are often amongst the most marginalised and 16 Coroners Court of Victoria. op cit. Pg 13 17 Coroners Court of Victoria. op cit. Pg 13 18 NSW Health. op cit. Pg192-193 19 Harm Reduction International. op cit. Pg 117 20 NSW Health. op cit. Pg x (Executive Summary) and Pg 20 VHA Submission - Page 4

vulnerable members of our society. Many have not engaged with treatment services before commencing engagement with a SIF. On average, it takes over three years for users to commence rehabilitation services in New South Wales. 21 Impressively, the Kings Cross facility was able to refer almost 1000 patients annually on average to support services include drug rehabilitation 22 between 2001 and 2010 and regular contact with the facility undoubtedly facilitated this outcome. 23 Increased Community Safety There is often a fear that the introduction of a safe injecting facility into an area will have a honey pot effect attracting further drug trade and crime. However, evaluation of the Kings Cross facility does not bear testament to these fears. 24 There is usually a short period of time from the purchase to self-administration of heroin for most users, leading to consumption of drugs in public areas. Since the commencement of the SIF in Kings Cross, local residents reported seeing less frequent public injecting and a slight reduction in presence of needles in public areas and there was no reported increase in crime activity in the local area. 25 People living in areas of significant heroin trade such as North Richmond regularly report observing public drug consumption, discovery of needles, drug dealing, ambulance responses and discovery of people experiencing overdose in places such as restaurant toilets. 26 They also describe feelings of anxiety about loss of safety and lament whether the presence of a SIF could possibly make things any worse. 27 Interestingly, support for the SIF in Kings Cross from its local community, businesses and health services has remained strong since it first opened. 28 There are concerns that reorienting the response to the harmful effects of heroin trade and consumption towards a more harm reduction approach may be sending the wrong message by encouraging drug use. However, focusing on harm reduction 21 Ross. Teeson, Darke et al, 2004. Cited in Chambers,J; Ritter,A; Heffernan,M; and McDonnell (2009). Modelling pharmacotherapy maintenance in Australia: exploring affordability, availability, accessability and quality using system dynamics: A report prepared for the Australian National Council on Drugs. Cited in NSW Health. Further evaluation of the Medically Supervised Injecting Centre during the extended Trial period (2007-2011). www.health.nsw.gov.au/mentalhealth/programs/da/documents/msic-kpmg.pdf Accessed 31/3/17 22 NSW Health. op cit. Pg x (Executive Summary) and Pg 20 23 NSW Health. op cit. Pg x (Executive Summary) and Pg 20 24 NSW Health. op cit. Pg ix (Executive Summary) and Pg 4 25 NSW Health. op cit. Pg ix (Executive Summary) and Pg 161-168 26 Cage, Carolyn. (2017) Richmond s heroin problem has gone from tragic to absurd. http://www.smh.com.au/comment/richmonds-heroin-problem-has-gone-from-tragic-to-absurd- 20170404-gvdd1q.html Accessed 7/4/17 27 Cage, Carolyn. op cit. 28 NSW Health. op cit. Pg 171-172 VHA Submission - Page 5

methods such as the introduction of a SIF would represent a pragmatic, evidence based approach that has significant community support in some areas of high heroin activity and experience of the Kings Cross facility demonstrates that a new SIF would likely evolve into a critical piece of health and social welfare infrastructure that would win further community support. In addition, such a facility will also be strongly supported by intravenous drug users. Indeed, our members inform us that users that attend their services can t believe that there isn t a supervised injecting facility already in place. VHA Recommendations That the Government: Implement a time limited trial of an integrated supervised injecting facility (SIF) similar to that recommended by Coroner Jacqui Hawkins at a site where there is significant drug trade and consumption of heroin. The facility should offer a range of services in addition to supervised injecting including (but not limited to) medical care, pharmacotherapy, referral to drug rehabilitation, housing, legal and other support services. Give consideration to this trial being part of a research study examining the operational and clinical benefits of operating a SIF in a Victorian context. Plan for a wider implementation of SIFs in areas of need across metropolitan Melbourne and regional Victoria at the conclusion of this trial About the VHA The VHA is the not-for-profit peak body supporting Victoria s public health and community services to deliver high quality care. We represent public sector health services, hospitals, registered community health services, multi-purpose services, and bush nursing services. 1. Further information For further information, contact: Tom Symondson Chief Executive Officer tom.symondson@ 03 9094 7777 VHA Submission - Page 6

Paul Tuvey Policy Advisor paul.tuvey@ 03 9094 7777 VHA Submission - Page 7